IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0203992.html
   My bibliography  Save this article

Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System

Author

Listed:
  • Gabriela Maria Reis Goncalves
  • Everton Nunes da Silva

Abstract

Introduction: Diabetes is the most common cause of chronic kidney disease, with a high economic impact on health systems. Objective: To estimate the cost of chronic kidney disease (CKD) and end-stage kidney disease (ESKD) attributable to diabetes, stratified by sex, race/skin color, and age, from the perspective of the Brazilian public health system between 2010 and 2016. Methods: Population attributable risk (PAR) was calculated from the Brazilian prevalence of diabetes and the relative risk (or odds ratio) of persons with diabetes developing CKD and ESKD as compared to non-diabetic subjects. The variables of interest were sex, race/skin color, and age. A top-down approach was used to measure the direct costs of the disease reimbursed by the Brazilian Ministry of Health, using data from outpatient and inpatient records. Results: The cost of CKD and ESKD attributable to diabetes in the period 2010–2016 was US$1.2 billion (US$180 million per year) and trending upward. Female sex, age 65–75, and black race/skin color contributed substantially to the costs of CKD and ESKD (US$475 million, US$63 million, and US$25 million respectively). The clinical procedures accounting for the greatest share of disease-attributable costs are hemodialysis and peritoneal dialysis. Conclusion: Diabetes accounted for 22% of the costs of CKD and ESKD. Female sex, age 65–75 years, and black race/skin color were the variables which contributed most to disease-related expenditure. The economic burden of CKD may increase gradually in the coming years, with serious implications for the financial sustainability of the Brazilian public health system.

Suggested Citation

  • Gabriela Maria Reis Goncalves & Everton Nunes da Silva, 2018. "Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-15, October.
    • Handle: RePEc:plo:pone00:0203992
    DOI: 10.1371/journal.pone.0203992
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0203992
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0203992&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0203992?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Loren Lipworth & Michael T Mumma & Kerri L Cavanaugh & Todd L Edwards & T Alp Ikizler & Robert E.Tarone & Joseph K McLaughlin & William J Blot, 2012. "Incidence and Predictors of End Stage Renal Disease among Low-Income Blacks and Whites," PLOS ONE, Public Library of Science, vol. 7(10), pages 1-7, October.
    2. Nathan R Hill & Samuel T Fatoba & Jason L Oke & Jennifer A Hirst & Christopher A O’Callaghan & Daniel S Lasserson & F D Richard Hobbs, 2016. "Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis," PLOS ONE, Public Library of Science, vol. 11(7), pages 1-18, July.
    3. Till Seuring & Olga Archangelidi & Marc Suhrcke, 2015. "The Economic Costs of Type 2 Diabetes: A Global Systematic Review," PharmacoEconomics, Springer, vol. 33(8), pages 811-831, August.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Eduardo Augusto Fernandes Nilson & Adriana Blanco Metlzer & Marie-Eve Labonté & Patrícia Constante Jaime, 2020. "Modelling the effect of compliance with WHO salt recommendations on cardiovascular disease mortality and costs in Brazil," PLOS ONE, Public Library of Science, vol. 15(7), pages 1-15, July.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Gabriela Ortiz, 2023. "New meta-analysis (MA) features in Stata 18: MA for prevalence and multilevel MA," Canadian Stata Conference 2023 06, Stata Users Group.
    2. William P Martin & Neil G Docherty & Carel W Le Roux, 2017. "Bariatric Surgery for the Treatment of Diabetic Kidney Disease," Current Research in Diabetes & Obesity Journal, Juniper Publishers Inc., vol. 3(5), pages 1-4, August.
    3. V Boima & K Agyabeng & V Ganu & D Dey & E Yorke & M B Amissah-Arthur & A A Wilson & A E Yawson & C C Mate-Kole & J Nonvignon, 2020. "Willingness to pay for kidney transplantation among chronic kidney disease patients in Ghana," PLOS ONE, Public Library of Science, vol. 15(12), pages 1-15, December.
    4. Clara Bermudez-Tamayo & Stéphane Besançon & Mira Johri & Sidibe Assa & Jonathan Betz Brown & Kaushik Ramaiya, 2017. "Direct and indirect costs of diabetes mellitus in Mali: A case-control study," PLOS ONE, Public Library of Science, vol. 12(5), pages 1-14, May.
    5. Haruhisa Fukuda & Shunya Ikeda & Takeru Shiroiwa & Takashi Fukuda, 2016. "The Effects of Diagnostic Definitions in Claims Data on Healthcare Cost Estimates: Evidence from a Large-Scale Panel Data Analysis of Diabetes Care in Japan," PharmacoEconomics, Springer, vol. 34(10), pages 1005-1014, October.
    6. Seuring, Till & Serneels, Pieter & Suhrcke, Marc & Bachmann, Max, 2020. "Diabetes, employment and behavioural risk factors in China: Marginal structural models versus fixed effects models," Economics & Human Biology, Elsevier, vol. 39(C).
    7. Elina Jussila & Kaisa Kotakorpi & Jouko Verho, 2022. "Prescription Behavior of Physicians in the Public and Private Sector," CESifo Working Paper Series 10186, CESifo.
    8. Christian T. Litchepah & Issidor. Noumba & Mohammadou. Nourou, 2022. "Does reducing violence against women improve children’s health? The case of Cameroon," International Journal of Research and Innovation in Social Science, International Journal of Research and Innovation in Social Science (IJRISS), vol. 6(6), pages 187-194, June.
    9. David Cuesta-Frau & Daniel Novák & Vacláv Burda & Daniel Abasolo & Tricia Adjei & Manuel Varela & Borja Vargas & Milos Mraz & Petra Kavalkova & Marek Benes & Martin Haluzik, 2019. "Influence of Duodenal–Jejunal Implantation on Glucose Dynamics: A Pilot Study Using Different Nonlinear Methods," Complexity, Hindawi, vol. 2019, pages 1-10, February.
    10. Rättö, Hanna & Kurko, Terhi & Martikainen, Jaana E. & Aaltonen, Katri, 2021. "The impact of a co-payment increase on the consumption of type 2 antidiabetics – A nationwide interrupted time series analysis," Health Policy, Elsevier, vol. 125(9), pages 1166-1172.
    11. Qingqing Cai & Louise H Dekker & Stephan J L Bakker & Martin H de Borst & Gerjan Navis, 2019. "Intraregional differences in renal function in the Northern Netherlands: The Lifelines Cohort Study," PLOS ONE, Public Library of Science, vol. 14(10), pages 1-15, October.
    12. Clémence Bussière & Nicolas Sirven & Thomas Rapp & Christine Sevilla‐Dedieu, 2020. "Adherence to medical follow‐up recommendations reduces hospital admissions: Evidence from diabetic patients in France," Health Economics, John Wiley & Sons, Ltd., vol. 29(4), pages 508-522, April.
    13. Gourzoulidis, George & Kourlaba, Georgia & Stafylas, Panagiotis & Giamouzis, Gregory & Parissis, John & Maniadakis, Nikolaos, 2017. "Association between copayment, medication adherence and outcomes in the management of patients with diabetes and heart failure," Health Policy, Elsevier, vol. 121(4), pages 363-377.
    14. François-Olivier Baudot & Anne-Sophie Aguadé & Thomas Barnay & Christelle Gastaldi-Ménager & Anne Fagot-Campagna, 2019. "Impact of type 2 diabetes on health expenditure: estimation based on individual administrative data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(5), pages 657-668, July.
    15. Isabelle Chort & Olivier Dagnelie, 2022. "Worms or sugar? Mass deworming treatment doubles the probability to suffer from diabetes ten to fifteen years later," Working papers of Transitions Energétiques et Environnementales (TREE) hal-03887621, HAL.
    16. Seuring, Till & Serneels, Pieter & Suhrcke, Marc, 2019. "The impact of diabetes on labour market outcomes in Mexico: A panel data and biomarker analysis," Social Science & Medicine, Elsevier, vol. 233(C), pages 252-261.
    17. Luz María Peña-Longobardo & Isaac Aranda-Reneo & Juan Oliva-Moreno & Svenja Litzkendorf & Isabelle Durand-Zaleski & Eduardo Tizzano & Julio López-Bastida, 2020. "The Economic Impact and Health-Related Quality of Life of Spinal Muscular Atrophy. An Analysis across Europe," IJERPH, MDPI, vol. 17(16), pages 1-12, August.
    18. John Pastor Ansah & Shawn Tan Yi Wei & Tessa Lui Shi Min, 2020. "An evaluation of the impact of aggressive diabetes and hypertension management on chronic kidney diseases at the population level: a simulation analysis," System Dynamics Review, System Dynamics Society, vol. 36(4), pages 497-522, October.
    19. Michael Ekholuenetale & Anthony Ike Wegbom & Clement Kevin Edet & Charity Ehimwenma Joshua & Amadou Barrow & Chimezie Igwegbe Nzoputam, 2023. "Impact of Chronic Diseases on Labour Force Participation among South African Women: Further Analysis of Population-Based Data," World, MDPI, vol. 4(1), pages 1-12, February.
    20. Hayfa Almutary & Nahla Tayyib, 2021. "Translation, Adaptation, and Validation of Chronic Kidney Disease Self-Management and Knowledge Instruments for People at Pre-Dialysis Stage in the Arab World," Clinical Nursing Research, , vol. 30(8), pages 1231-1240, November.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0203992. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.